Stojanovic Danijela sold $32K of GEMI

Jim Cramer advised holding Gemini Space Station (GEMI) as a speculative investment. The company reported Q2 revenue of $45.5M, up 37% YoY, driven by non-transaction services. However, exchange revenue fell 38% YoY, and the company posted a net loss of $0.89 per share. GEMI's stock has declined significantly since its IPO, with a current market cap of $540M.

Gemini (GEMI) launched commission-free stock trading for U.S. customers, joining Coinbase (COIN), Kraken, and Block's (XYZ) Cash App. GEMI shares dropped 6% amid a broader market pullback, despite bullish retail sentiment. Bitcoin (BTC) fell below $63,000 after a Monday rally. Gemini aims to expand beyond crypto, as outlined in its Q4 2025 shareholder letter.

An arbitrator ruled that Gemini (GEMI) is not liable for the collapse of its Earn lending program, attributing the failure to Genesis' fraud. The program, which offered up to 7.4% annual interest, halted withdrawals in 2022. Gemini has since repaid 97% of owed assets to investors. GEMI stock is down 87% since its IPO, trading at $4.30.

Gemini Space Station (GEMI) shares rose 11.5% after announcing expansion into prediction markets and a potential partnership with Apex Fintech Solutions for exclusive crypto contract settlement. The deal, though not yet finalized, could include sports, economics, and financial-market contracts. Regulatory risks were noted by an analyst.

Gemini Space Station (GEMI) reported a $107.7M net loss for Q2 2026, improving 19% YoY. Revenue rose 37% to $45.5M, driven by credit card and staking revenue growth, while exchange revenue fell 38%. Monthly users increased 11% to 580K, but platform assets dropped 54% to $8.4B. CEO Tyler Winklevoss noted progress in cost-cutting and revenue diversification. Shares fell over 7% post-earnings.

Gemini Space Station (NASDAQ: GEMI) shares fell 9.1% by 11:30 a.m. ET, after earlier dropping up to 13.8%, and were down about 64.5% YTD. The selloff followed multiple analysts cutting price targets, including Rosenblatt ($9 to $6), Mizuho ($8 to $7), Needham ($8 to $6), and Goldman Sachs ($4 to $3.50). The article cites Q2 results: loss of $0.89/share on $45.5M revenue versus estimates of -$0.71 on ~$43.5M.